Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

William Sawchuk

Dermatology Vienna, VA Medical Doctor

NPI 1205954542 CMS profile 100240

8320 Old Courthouse Rd, Suite 303, Vienna, VA 22182

Open in the dashboard

General payments

$36,154

114 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, William Sawchuk of Vienna, VA is reported in the CMS Open Payments database as having received $36,154 across 114 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $350 8
2021 General $4,767 15
2020 General $7,242 16
2019 General $23,794 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Sawchuk
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to William Sawchuk were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year William Sawchuk Dermatology median Middle half National median
2019 $23,794 $454 $129–$1,240 $163
2020 $7,242 $235 $81–$756 $114
2021 $4,767 $377 $108–$1,108 $132
2022 $350 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Galderma Laboratories, L.P. $17,669 36 payments
  2. AbbVie, Inc. $17,255 42 payments
  3. Regeneron Healthcare Solutions, Inc. $161 6 payments
  4. EPI Health, LLC $160 2 payments
  5. Ortho Dermatologics, a division of Bausch Health US, LLC $148 5 payments
  6. Incyte Corporation $139 1 payment
  7. E.R. Squibb & Sons, L.L.C. $118 1 payment
  8. Janssen Scientific Affairs, LLC $104 1 payment
  9. UCB, Inc. $81 4 payments
  10. Celgene Corporation $58 2 payments
  11. Other $260 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,844 20 payments
  2. Food and Beverage $4,021 81 payments
  3. Travel and Lodging $1,268 10 payments
  4. Education $20 3 payments
Products named General payments · program years 2019–2022
  1. SOOLANTRA $14,228 27 payments
  2. SKYRIZI $10,947 31 payments
  3. ORACEA $8,581 14 payments
  4. HUMIRA $5,187 14 payments
  5. EPIDUO FORTE $322 7 payments
  6. AKLIEF $163 2 payments
  7. DUPIXENT $161 6 payments
  8. Minolira 105mg $160 2 payments
  9. Rhofade $160 2 payments
  10. Minolira 135mg $160 2 payments
  11. Other $1,452 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record